4592 — SanBio Co Income Statement
0.000.00%
Last trade - 00:00
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 447 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,943 | 5,802 | 6,602 | 7,899 | 4,291 |
Operating Profit | -5,496 | -5,802 | -6,602 | -7,899 | -4,291 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5,157 | -3,211 | -4,560 | -4,697 | -2,542 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5,158 | -3,386 | -4,678 | -5,560 | -2,644 |
Net Income Before Extraordinary Items | |||||
Net Income | -5,158 | -3,386 | -4,678 | -5,560 | -2,644 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5,158 | -3,386 | -4,678 | -5,560 | -2,644 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -101 | -65.4 | -90.6 | -96 | -43.3 |
Dividends per Share |